Joel C. Bronstein

1.1k total citations
24 papers, 840 citations indexed

About

Joel C. Bronstein is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Joel C. Bronstein has authored 24 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Epidemiology. Recurrent topics in Joel C. Bronstein's work include Herpesvirus Infections and Treatments (6 papers), Virus-based gene therapy research (5 papers) and Aldose Reductase and Taurine (5 papers). Joel C. Bronstein is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Virus-based gene therapy research (5 papers) and Aldose Reductase and Taurine (5 papers). Joel C. Bronstein collaborates with scholars based in United States, Sweden and Canada. Joel C. Bronstein's co-authors include Arthur W. Bull, Peter Weber, Jay L. Hess, Kajal Sitwala, Yongsheng Huang, Andrew G. Muntean, A W Bull, Jiaying Tan, Kojo S.J. Elenitoba‐Johnson and James A. Connelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Gastroenterology.

In The Last Decade

Joel C. Bronstein

24 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel C. Bronstein United States 16 554 172 123 105 92 24 840
Wenjing Chen China 17 665 1.2× 166 1.0× 51 0.4× 30 0.3× 16 0.2× 64 1.0k
Christian Apfel Switzerland 14 879 1.6× 36 0.2× 81 0.7× 349 3.3× 20 0.2× 21 1.1k
Wei‐Xin Hu China 17 477 0.9× 84 0.5× 40 0.3× 116 1.1× 9 0.1× 66 999
R. J. L. Munks United Kingdom 10 516 0.9× 24 0.1× 62 0.5× 80 0.8× 25 0.3× 17 933
Ian Parsons Australia 12 478 0.9× 112 0.7× 23 0.2× 23 0.2× 21 0.2× 29 790
Francesco Fiorentino Italy 19 630 1.1× 26 0.2× 127 1.0× 69 0.7× 27 0.3× 50 1.0k
Wolfgang Pirson Switzerland 11 421 0.8× 22 0.1× 73 0.6× 141 1.3× 19 0.2× 14 690
Shigeru Hoshiko Japan 15 386 0.7× 15 0.1× 52 0.4× 172 1.6× 59 0.6× 30 851
Fei Qiu China 14 562 1.0× 100 0.6× 33 0.3× 45 0.4× 17 0.2× 35 708
A.S.R. Donald United Kingdom 19 705 1.3× 164 1.0× 38 0.3× 70 0.7× 25 0.3× 37 980

Countries citing papers authored by Joel C. Bronstein

Since Specialization
Citations

This map shows the geographic impact of Joel C. Bronstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel C. Bronstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel C. Bronstein more than expected).

Fields of papers citing papers by Joel C. Bronstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel C. Bronstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel C. Bronstein. The network helps show where Joel C. Bronstein may publish in the future.

Co-authorship network of co-authors of Joel C. Bronstein

This figure shows the co-authorship network connecting the top 25 collaborators of Joel C. Bronstein. A scholar is included among the top collaborators of Joel C. Bronstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel C. Bronstein. Joel C. Bronstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collins, Cailin, Jingya Wang, Hongzhi Miao, et al.. (2014). C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis. PMC. 1 indexed citations
2.
Warmus, Joseph S., Cheryl L. Quinn, Clarke Taylor, et al.. (2012). Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC. Bioorganic & Medicinal Chemistry Letters. 22(7). 2536–2543. 28 indexed citations
3.
Huang, Yongsheng, Kajal Sitwala, Joel C. Bronstein, et al.. (2011). Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood. 119(2). 388–398. 137 indexed citations
4.
Muntean, Andrew G., Jiaying Tan, Kajal Sitwala, et al.. (2010). The PAF Complex Synergizes with MLL Fusion Proteins at HOX Loci to Promote Leukemogenesis. Cancer Cell. 17(6). 609–621. 179 indexed citations
5.
Ellsworth, Edmund L., Tuan P. Tran, Hollis D. Showalter, et al.. (2006). 3-Aminoquinazolinediones as a New Class of Antibacterial Agents Demonstrating Excellent Antibacterial Activity Against Wild-Type and Multidrug Resistant Organisms. Journal of Medicinal Chemistry. 49(22). 6435–6438. 49 indexed citations
6.
Bronstein, Joel C. & Peter Weber. (2001). A Colorimetric Assay for High-Throughput Screening of Inhibitors of Herpes Simplex Virus Type 1 Alkaline Nuclease. Analytical Biochemistry. 293(2). 239–245. 12 indexed citations
7.
Bronstein, Joel C. & Peter Weber. (2001). Purification of a Bacterially Expressed Herpes Simplex Virus Type 1 Origin Binding Protein for Use in Posttranslational Processing Studies. Protein Expression and Purification. 22(2). 276–285. 3 indexed citations
9.
Bronstein, Joel C. & Arthur W. Bull. (1997). Substrate Specificity and Characterization of Partially Purified Rat Liver 13-Hydroxyoctadecadienoic Acid (13-HODE) Dehydrogenase. Archives of Biochemistry and Biophysics. 348(1). 219–225. 9 indexed citations
10.
Bronstein, Joel C., Sandra K. Weller, & Peter Weber. (1997). The product of the UL12.5 gene of herpes simplex virus type 1 is a capsid-associated nuclease. Journal of Virology. 71(4). 3039–3047. 23 indexed citations
12.
Bull, Arthur W., et al.. (1996). Formation of adducts between 13-oxooctadecadienoic acid (13-OXO) and protein- derived thiols, in vivo and in vitro. Life Sciences. 58(25). 2355–2365. 14 indexed citations
13.
Silverman, Ann L., et al.. (1996). Decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE) dehydrogenase in neoplastic tissue of human colon biopsies.. PubMed. 5(1). 53–6. 18 indexed citations
14.
Bronstein, Joel C. & A W Bull. (1993). The correlation between 13-hydroxyoctadecadienoate dehydrogenase (13-HODE dehydrogenase) and intestinal cell differention. Prostaglandins. 46(5). 387–395. 31 indexed citations
15.
Bull, Arthur W., et al.. (1993). Increases in 13-hydroxyoctadecadienoic acid dehydrogenase activity during differentiation of cultured cells. Carcinogenesis. 14(11). 2239–2243. 25 indexed citations
16.
Desai, Tusar K., et al.. (1992). Failure of rectal ornithine decarboxylase to identify adenomatous polyp status. Gastroenterology. 103(5). 1562–1567. 10 indexed citations
18.
Bronstein, Joel C., et al.. (1991). Metabolism of oxidized linoleic acid: characterization of 13-hydroxyoctadecadienoic acid dehydrogenase activity from rat colonic tissue. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1081(2). 174–180. 48 indexed citations
19.
Bull, Arthur W. & Joel C. Bronstein. (1990). Production of unsaturated carbonyl compounds during metabolism of hydroperoxy fatty acids by colonic homogenates. Carcinogenesis. 11(10). 1699–1704. 23 indexed citations
20.
Bull, Arthur W., Joel C. Bronstein, & Norman D. Nigro. (1989). The essential fatty acid requirement for azoxymethane‐induced intestinal carcinogenesis in rats. Lipids. 24(4). 340–346. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026